HSD17B7
Basic information
Region (hg38): 1:162790702-162812823
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HSD17B7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 30 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 30 | 3 | 3 |
Variants in HSD17B7
This is a list of pathogenic ClinVar variants found in the HSD17B7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-162790823-C-G | not specified | Uncertain significance (Dec 20, 2024) | ||
1-162790826-G-C | not specified | Uncertain significance (Sep 12, 2024) | ||
1-162790831-A-G | not specified | Uncertain significance (May 12, 2024) | ||
1-162790832-G-C | Benign (Oct 10, 2018) | |||
1-162792673-C-T | not specified | Uncertain significance (May 22, 2023) | ||
1-162792683-G-C | not specified | Uncertain significance (Jan 04, 2024) | ||
1-162792691-T-C | not specified | Uncertain significance (Nov 17, 2022) | ||
1-162792693-G-C | not specified | Uncertain significance (Apr 21, 2022) | ||
1-162792694-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
1-162792757-G-C | not specified | Uncertain significance (Jun 30, 2023) | ||
1-162792778-A-G | not specified | Uncertain significance (Jan 22, 2025) | ||
1-162792800-T-G | not specified | Uncertain significance (Dec 04, 2023) | ||
1-162792837-C-T | not specified | Uncertain significance (Nov 08, 2024) | ||
1-162792847-A-G | not specified | Uncertain significance (Feb 25, 2025) | ||
1-162792856-A-G | not specified | Uncertain significance (Jan 19, 2024) | ||
1-162796604-A-G | not specified | Likely benign (Mar 25, 2024) | ||
1-162796652-G-A | not specified | Uncertain significance (Mar 29, 2023) | ||
1-162797812-C-A | not specified | Uncertain significance (Aug 23, 2021) | ||
1-162797820-C-A | not specified | Uncertain significance (Jul 05, 2024) | ||
1-162797824-A-G | not specified | Uncertain significance (Aug 05, 2024) | ||
1-162797848-G-C | not specified | Uncertain significance (Nov 10, 2022) | ||
1-162797888-A-C | not specified | Uncertain significance (Apr 20, 2023) | ||
1-162797889-G-A | Benign (Sep 09, 2018) | |||
1-162797915-T-C | not specified | Uncertain significance (Nov 08, 2022) | ||
1-162799749-G-A | not specified | Uncertain significance (Jun 06, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HSD17B7 | protein_coding | protein_coding | ENST00000254521 | 9 | 22116 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000665 | 0.726 | 125721 | 0 | 27 | 125748 | 0.000107 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.588 | 159 | 181 | 0.877 | 0.00000905 | 2236 |
Missense in Polyphen | 41 | 53.917 | 0.76042 | 653 | ||
Synonymous | -0.353 | 74 | 70.2 | 1.05 | 0.00000355 | 660 |
Loss of Function | 1.12 | 10 | 14.6 | 0.684 | 6.16e-7 | 182 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000211 | 0.000211 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000793 | 0.0000791 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Responsible for the reduction of the keto group on the C-3 of sterols. {ECO:0000269|PubMed:12829805}.;
- Pathway
- Steroid hormone biosynthesis - Homo sapiens (human);Steroid biosynthesis - Homo sapiens (human);Ovarian steroidogenesis - Homo sapiens (human);Simvastatin Action Pathway;Pravastatin Action Pathway;Atorvastatin Action Pathway;Hyper-IgD syndrome;Cholesteryl ester storage disease;Lysosomal Acid Lipase Deficiency (Wolman Disease);Alendronate Action Pathway;Rosuvastatin Action Pathway;Lovastatin Action Pathway;Mevalonic aciduria;Wolman disease;Risedronate Action Pathway;Cerivastatin Action Pathway;Pamidronate Action Pathway;Fluvastatin Action Pathway;Smith-Lemli-Opitz Syndrome (SLOS);Chondrodysplasia Punctata II, X Linked Dominant (CDPX2);CHILD Syndrome;Desmosterolosis;Hypercholesterolemia;Steroid Biosynthesis;Zoledronate Action Pathway;Ibandronate Action Pathway;Androgen Receptor Network in Prostate Cancer;Steroid Biosynthesis;Metabolism of lipids;zymosterol biosynthesis;Metabolism;cholesterol biosynthesis III (via desmosterol);cholesterol biosynthesis II (via 24,25-dihydrolanosterol);superpathway of cholesterol biosynthesis;Metabolism of steroids;cholesterol biosynthesis I;Cholesterol biosynthesis;estradiol biosynthesis I;superpathway of steroid hormone biosynthesis
(Consensus)
Intolerance Scores
- loftool
- 0.478
- rvis_EVS
- 0.02
- rvis_percentile_EVS
- 55.22
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.332
- ghis
- 0.517
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.893
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hsd17b7
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; growth/size/body region phenotype; muscle phenotype; craniofacial phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- cholesterol biosynthetic process;estrogen biosynthetic process;oxidation-reduction process
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;integral component of membrane
- Molecular function
- 3-keto sterol reductase activity;estradiol 17-beta-dehydrogenase activity